**Question:** All are used for treatment of pulmonary hypertension EXCEPT:

A. **Option A:** Methylene Blue
B. **Option B:** Nitroprusside
C. **Option C:** Theophylline
D. **Option D:** Oxygen therapy

**Core Concept:**
Pulmonary hypertension is a condition characterized by an increase in blood pressure within the pulmonary circulation, leading to symptoms such as dyspnea, fatigue, and right-sided heart failure. Treatment options aim to reduce pulmonary vascular resistance and improve oxygenation.

**Why the Correct Answer is Right:**
The correct answer, Oxygen therapy (Option D), is not used for the treatment of pulmonary hypertension as it primarily addresses hypoxia and not the increased pulmonary vascular resistance that underlies the condition. Oxygen therapy is essential in correcting low oxygen levels in the body, but it does not directly target the pulmonary hypertension itself.

**Why Each Wrong Option is Incorrect:**

A. Methylene Blue (Option A) is a drug used to treat methemoglobinemia, a condition characterized by increased methemoglobin levels in the blood. It does not have a direct impact on pulmonary hypertension.

B. Nitroprusside (Option B) is a vasodilator that lowers blood pressure by relaxing blood vessels. While it can be used in certain cardiovascular conditions, it is not a specific treatment for pulmonary hypertension.

C. Theophylline (Option C) is a phosphodiesterase inhibitor used to treat bronchoconstriction in asthma and other respiratory conditions. It is not a primary treatment for pulmonary hypertension.

**Clinical Pearl:**
When dealing with pulmonary hypertension, it is essential to consider the specific condition and its underlying pathophysiology when choosing suitable treatment options. In this case, oxygen therapy is not the appropriate treatment for pulmonary hypertension, while the other options are targeted at different medical conditions.